Group items tagged US - medindia

Snakes Can Give Really Useful Advice on Heart Health | MedIndia - 0 views

www.medindia.net/...ce-on-Heart-Health-92614-1.htm

Science health US animal heart daily news for the day dental pharma medical breakthroughs topic

shared by med india on 29 Oct 11 - No Cached

med india on 29 Oct 11

Snakes get a bad rap for being slimy, cold-hearted creatures, but US researchers said Thursday some actually have huge hearts that could offer clues to treating people with cardiac disease.

<div class="cArrow"> </div><div class="cContentInner">Snakes get a bad rap for being slimy, cold-hearted creatures, but US researchers said Thursday some actually have huge hearts that could offer clues to treating people with cardiac disease.</div>

...

Cancel

The Best Ideal Home Fitness Equipment Calgary - 1 views

If you want to really get into shape and tone and build your muscle while cutting fat, then perhaps the best way to do this is using home fitness equipment calgary which has many advantages over go...

Fitness equipment calgary

started by Gran Trabajo on 30 Apr 12 no follow-up yet

Pluristem files orphan drug application to US FDA for preeclampsia - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...or-preeclampsia-210214-4182176

health pharma news

shared by Alex Parker on 24 Feb 14 - No Cached

Alex Parker on 24 Feb 14

PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.</div>

...

Cancel

Teva launches generic Xeloda tablets in US - 1 views

processandproduction.pharmaceutical-business-review.com/...a-tablets-in-us-100314-4192411

health news pharma daily

shared by Alex Parker on 11 Mar 14 - No Cached

Alex Parker on 11 Mar 14

Teva Pharmaceutical Industries has launched the generic equivalent to Xeloda tablets, 150mg and 500mg, in the US.

<div class="cArrow"> </div><div class="cContentInner">Teva Pharmaceutical Industries has launched the generic equivalent to Xeloda tablets, 150mg and 500mg, in the US.</div>

...

Cancel

Developing Self Confidence In Children - 1 views

My husband and I were really worried with the indifference that our second child has been showing. We noticed that she did not like to mingle with other kids in the class. Her teacher even told us ...

started by Child Therapy on 29 Nov 12 no follow-up yet

Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...r-based-regimen-250214-4183423

health medical news pharma breakthroughs

shared by Alex Parker on 25 Feb 14 - No Cached

Alex Parker on 25 Feb 14

PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).</div>

...

Cancel

Vertex gets FDA approval for Kalydeco sNDA - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...r-kalydeco-snda-240214-4182411

health medical news pharma day

shared by Alex Parker on 24 Feb 14 - No Cached

Alex Parker on 24 Feb 14

PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).</div>

...

Cancel

Edison's EPI-743 gets FDA fast track status to treat Friedreich's Ataxia - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...reat-friedreichs-ataxia-180314

health news medical pharma daily

shared by Alex Parker on 18 Mar 14 - No Cached

Alex Parker on 18 Mar 14

US-based Edison Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for its lead drug EPI-743 to treat patients with Friedreich's ataxia.

<div class="cArrow"> </div><div class="cContentInner">US-based Edison Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for its lead drug EPI-743 to treat patients with Friedreich's ataxia.</div>

...

Cancel

KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views

drugdelivery.pharmaceutical-business-review.com/...d-submental-fat-130514-4265243

health news medical pharma

shared by Alex Parker on 13 May 14 - No Cached

Alex Parker on 13 May 14

US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.

<div class="cArrow"> </div><div class="cContentInner">US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.</div>

...

Cancel

FDA approves Xolair for treatment of chronic hives - 1 views

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

med india on 11 Oct 11

Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.

<div class="cArrow"> </div><div class="cContentInner">Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.</div>

...

Cancel

Drug Therapy for Inherited Kidney Disease on the Anvil | MedIndia - 0 views

med india on 31 Oct 11

Patients with an inherited kidney disease may be helped by a drug that is currently available for other uses, scientists at UC Santa Barbara have discovered.

<div class="cArrow"> </div><div class="cContentInner">Patients with an inherited kidney disease may be helped by a drug that is currently available for other uses, scientists at UC Santa Barbara have discovered.</div>

...

Cancel

Light Drinking Ups Breast Cancer Risk | MedIndia - 0 views

shared by med india on 02 Nov 11 - No Cached

med india on 02 Nov 11

Light alcohol intake linked to increased risk of breast cancer, finds US study.

<div class="cArrow"> </div><div class="cContentInner">Light alcohol intake linked to increased risk of breast cancer, finds US study.</div>

...

Cancel

Goodwin, Aspyrian partner for cGMP manufacturing of new antibody drug conjugate - 1 views

manufacturing.pharmaceutical-business-review.com/...-drug-conjugate-250314-4203321

health news medical pharma

shared by Alex Parker on 26 Mar 14 - No Cached

Alex Parker on 26 Mar 14

PBR Staff Writer Published 25 March 2014 US-based Goodwin Biotechnology has entered into an agreement with Aspyrian Therapeutics for the technology transfer, process development, scale-up, and cGMP manufacturing of a new Antibody Drug Conjugate (ADC) for use in Phase I clinical trials.

<div class="cArrow"> </div><div class="cContentInner">PBR Staff Writer Published 25 March 2014 US-based Goodwin Biotechnology has entered into an agreement with Aspyrian Therapeutics for the technology transfer, process development, scale-up, and cGMP manufacturing of a new Antibody Drug Conjugate (ADC) for use in Phase I clinical trials.</div>

...

Cancel

Losing Weight The Healthy Way - 1 views

I admit it was not that easy for me to lose weight. In fact, I have used a lot of products that did not work and I have spent a long period of time in the gym, yet nothing happened. I was about to ...

started by Edgar Anderson on 28 Nov 12 no follow-up yet

Prevention Cream For Stretch Marks - 1 views

I was really afraid to get pregnant because I knew then that my skin will be prone to stretch marks. That is why I have researched on How to get rid of stretch marks to prevent it from appearing o...

Prevention Cream For Stretch Marks skin care health

started by Stretch Marks on 28 Mar 12 no follow-up yet

Effective Stretch Mark Remedy - 1 views

I gave birth six months ago. What bothers me are these stretch marks that are found in my belly. I could not wear my swim wear attire whenever my family would decide to stay at the beach to swim. I...

stretch mark cream

started by Justin Stone on 29 Feb 12 no follow-up yet

Immuneering expands relationship with Bristol-Myers Squibb - 0 views

itsoftware.pharmaceutical-business-review.com/...ol-myers-squibb-300114-4168880

health medical news pharma

shared by Alex Parker on 31 Jan 14 - No Cached

Alex Parker on 31 Jan 14

Immuneering has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb (BMS) for the use of Immuneering's proprietary computational biology methods to identify biological insights that would help in the discovery and development of medicines.

<div class="cArrow"> </div><div class="cContentInner">Immuneering has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb (BMS) for the use of Immuneering's proprietary computational biology methods to identify biological insights that would help in the discovery and development of medicines.</div>

...

Cancel

Otsuka- Lundbeck's schizophrenia drug Abilify Maintena gets Health Canada clearance - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...roved-in-canada-140214-4177946

health medical news pharma

shared by Alex Parker on 17 Feb 14 - No Cached

Alex Parker on 17 Feb 14

Otsuka and Lundbeck has received approval from Health Canada to use its intramuscular (IM) once-monthly injectable formulation 'Abilify Maintena' for the maintenance treatment of schizophrenia in stabilized adult patients.

<div class="cArrow"> </div><div class="cContentInner">Otsuka and Lundbeck has received approval from Health Canada to use its intramuscular (IM) once-monthly injectable formulation 'Abilify Maintena' for the maintenance treatment of schizophrenia in stabilized adult patients.</div>

...

Cancel

DARPA's vaccine manufacturing challenge - 0 views

www.pharmaceutical-technology.com/...anufacturing-challenge-4171658

health medical news pharma

shared by Alex Parker on 13 Feb 14 - No Cached

Alex Parker on 13 Feb 14

The prospect of global pandemic is worrying for public health authorities, with the sufficient supply of vaccines a particular concern. In the US, DARPA's Blue Angel project has been working on alternative plant-based vaccine production methods, with impressive results.

<div class="cArrow"> </div><div class="cContentInner">The prospect of global pandemic is worrying for public health authorities, with the sufficient supply of vaccines a particular concern. In the US, DARPA's Blue Angel project has been working on alternative plant-based vaccine production methods, with impressive results.</div>

...

Cancel

Group items tagged

Snakes Can Give Really Useful Advice on Heart Health | MedIndia - 0 views

The Best Ideal Home Fitness Equipment Calgary - 1 views

Pluristem files orphan drug application to US FDA for preeclampsia - 0 views

Teva launches generic Xeloda tablets in US - 1 views

Developing Self Confidence In Children - 1 views

Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views

Vertex gets FDA approval for Kalydeco sNDA - 0 views

Edison's EPI-743 gets FDA fast track status to treat Friedreich's Ataxia - 1 views

KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views

FDA approves Xolair for treatment of chronic hives - 1 views

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

Drug Therapy for Inherited Kidney Disease on the Anvil | MedIndia - 0 views

Light Drinking Ups Breast Cancer Risk | MedIndia - 0 views

Goodwin, Aspyrian partner for cGMP manufacturing of new antibody drug conjugate - 1 views

Losing Weight The Healthy Way - 1 views

Prevention Cream For Stretch Marks - 1 views

Effective Stretch Mark Remedy - 1 views

Immuneering expands relationship with Bristol-Myers Squibb - 0 views

Otsuka- Lundbeck's schizophrenia drug Abilify Maintena gets Health Canada clearance - 0 views

DARPA's vaccine manufacturing challenge - 0 views

Related searches